Sutter Health California Pacific Medical Center is a general medical/surgical and teaching hospital in San Francisco, California. It was created by a merger of some of the city's longest established hospitals and currently operates three acute care campuses.

During the past decade, Davies Med Ctr conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Davies Med Ctr" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Glaxo Wellcome" with 3 trials sponsored and "Pharmacia and Upjohn" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Davies Med Ctr" #1 collaborator was "Hoffmann-La Roche" with 3 trials as a collaborator, "Medical University of South Carolina" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Neurological Emergencies Treatment Trials Network (NETT)" with 2 trials as a collaborator and "University of Calgary" with 2 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Davies Med Ctr" are "HIV Infections" (31 trials), "Cytomegalovirus Retinitis" (5 trials), "Cytomegalovirus Infections" (2 trials), "Meningitis, Cryptococcal" (2 trials) and "Acute Ischemic Stroke" (1 trials). Many other conditions were trialed in "Davies Med Ctr" in a lesser frequency.

Most popular intervention types in "Davies Med Ctr" are "Drug" (35 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (10 trials), "Ganciclovir" (6 trials), "Lamivudine" (5 trials), "Zalcitabine" (5 trials) and "Saquinavir" (4 trials). Other intervention names were less common.

The vast majority of trials in "Davies Med Ctr" are 34 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Davies Med Ctr". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Davies Med Ctr, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Davies Med Ctr, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".